Comparative Pharmacology
Head-to-head clinical analysis: LIPOSYN II 20 versus LIPOSYN III 20.
Peer-Reviewed Evidence
Head-to-head clinical analysis: LIPOSYN II 20 versus LIPOSYN III 20.
LIPOSYN II 20% vs LIPOSYN III 20%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories for parenteral nutrition. The triglycerides are hydrolyzed by lipoprotein lipase to free fatty acids and glycerol, which are then utilized for energy or stored.
Liposyn III 20% is a lipid emulsion providing essential fatty acids (linoleic and linolenic acids) and calories. It serves as a source of energy and prevents essential fatty acid deficiency by supplying triglycerides that are hydrolyzed to free fatty acids and glycerol for metabolism.
Intravenous fat emulsion; 20% formulation: Initial rate 1 mL/min for 15-30 minutes, then increase to 2 mL/min if tolerated. Max infusion rate: 100 mL/hour. Total daily dose: 1-2 g/kg (5-10 mL/kg) to provide up to 60% of nonprotein calories.
Adults: 500 mL to 2500 mL per day via continuous intravenous infusion (including peripheral or central vein); typical rate: 0.5-1 mL/kg/h initially, increasing to 1.5-2 mL/kg/h as tolerated. Maximum infusion rate: 2.5 mL/kg/h.
None Documented
None Documented
Terminal elimination half-life of triglycerides is approximately 30 minutes for the fast phase and 12-24 hours for the slow phase, reflecting clearance from plasma and tissue distribution.
The terminal elimination half-life of infused triglycerides is approximately 0.5–1 h (33–60 min). Clearance is saturable; at high infusion rates, half-life may prolong.
Intravenous lipid emulsions are metabolized by lipoprotein lipase and eliminated as free fatty acids; less than 1% excreted unchanged in urine, negligible biliary/fecal excretion.
Primarily eliminated via endogenous lipid metabolic pathways (beta-oxidation in tissues). <5% excreted unchanged in urine; minimal biliary/fecal elimination.
Category C
Category C
Intravenous Fat Emulsion
Intravenous Fat Emulsion